EUCRATES BIOMEDICAL ACQU COR - *W EXP 10/23/202 (EUCRW)

CUSIP: G3141W122

Q1 2021 13F Holders as of 31 Mar 2021

Type / Class
Equity / *W EXP 10/23/202
Total 13F shares
891,476
Share change
+543,556
Total reported value
$1,115,000
Price per share
$1.25
Number of holders
10
Value change
+$649,000
Number of buys
7
Number of sells
1

Quarterly Holders Quick Answers

What is CUSIP G3141W122?
CUSIP G3141W122 identifies EUCRW - EUCRATES BIOMEDICAL ACQU COR - *W EXP 10/23/202 in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of EUCRATES BIOMEDICAL ACQU COR - *W EXP 10/23/202 (EUCRW) as of Q1 2021

As of 31 Mar 2021, EUCRATES BIOMEDICAL ACQU COR - *W EXP 10/23/202 (EUCRW) was held by 10 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 891,476 shares. The largest 10 holders included BlackRock Inc., 683 Capital Management, LLC, Granite Point Capital Management, L.P., Monashee Investment Management LLC, COWEN AND COMPANY, LLC, SUVRETTA CAPITAL MANAGEMENT, LLC, RIVERNORTH CAPITAL MANAGEMENT, LLC, JANE STREET GROUP, LLC, UBS Group AG, and Exos Asset Management LLC. This page lists 10 institutional shareholders reporting positions in this security for the Q1 2021 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.